News | February 03, 2022
Caplin Point Q3FY22 PAT at Rs 74.95 cr.
Caplin Point Laboratories has reported consolidated financial results for the period ended December 31, 2021.
Caplin Point Laboratories has reported consolidated financial results for the period ended December 31, 2021.
The Board of Directors of Caplin Point Laboratories at its meeting have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
The approval allows it to market its products in the country
EPS climbs to Rs 9.25 for the quarter
Acetaminophen Injection is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older
Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or desirable
Milrinone is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure
Haloperidol Decanoate Injection indicated for the treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy
Phytonadione Injectable Emulsion possesses the same type and degree of activity as does naturally-occurring vitamin K
Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure
Subscribe To Our Newsletter & Stay Updated
